IBA Half Year Results 2022 Press release and presentation

Louvain-la-Neuve, Belgium, 11 July 2022 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today that it will publish its consolidated results for the half year 2022 on Wednesday, 31 August 2022 at 7am CEST.

Conference Call Information
Olivier Legrain, Chief Executive Officer, and Soumya Chandramouli, Chief Financial Officer, will host a hybrid event, including a conference call and webcast, conducted in English, to present the half year results, followed by a Q&A session.

The conference call will be held on Wednesday,31 August 2022 at 3pm CEST / 2pm BST / 9am EDT / 6amPDT as a Teams webinar and can be accessed online on this link.

If you would like to join by phone only, please dial (Phone conference ID 495 140 424#):

Belgium:                     +32 2 890 97 20

UK:                             +44 20 3321 5200

NL:                              +31 20 708 6901

LU:                              +352 27 87 00 02

US:                             +1 347-991-7591

FR:                              +33 1 70 99 53 51

The presentation will be available on IBA’s investor relations website and on:
https://www.iba-worldwide.com/content/iba-half-year-results-2022-press-release-and-presentation  shortly before the call.

To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast. 

For participants who do not have the Teams application installed, please follow the process described in this link to access the conference.